Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006198
Filing Date
2005-03-11
Accepted
2005-03-11 15:27:36
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2153324z10-k.htm 10-K 661756
2 EXHIBIT 10.26 a2153324zex-10_26.txt EX-10.26 17330
3 EXHIBIT 10.27 a2153324zex-10_27.txt EX-10.27 2084
4 EXHIBIT 10.28 a2153324zex-10_28.txt EX-10.28 1487
5 EXHIBIT 10.29 a2153324zex-10_29.txt EX-10.29 21608
6 EXHIBIT 10.30 a2153324zex-10_30.txt EX-10.30 12590
7 EXHIBIT 23.1 a2153324zex-23_1.htm EX-23.1 2663
8 EXHIBIT 31.1 a2153324zex-31_1.htm EX-31.1 6144
9 EXHIBIT 31.2 a2153324zex-31_2.htm EX-31.2 6222
10 EXHIBIT 32 a2153324zex-32.htm EX-32 2843
  Complete submission text file 0001047469-05-006198.txt   737392
Mailing Address 71 ROGERS ST CAMBRIDGE MA 02142-1118
Business Address 71 ROGERS ST CAMBRIDGE MA 02142-1118 6172506000
EPIX Pharmaceuticals, Inc. (Filer) CIK: 0001027702 (see all company filings)

EIN.: 043030815 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21863 | Film No.: 05675388
SIC: 2835 In Vitro & In Vivo Diagnostic Substances